5Galli E, Cieeoni R, Ressi P, et al. Atopic dermatitis: molecularmechanisms, clinical aspects and new therapeutical approaches [J].Curt Mol Med, 2003, 3 (2): 127 -138.
6Gmnlund MM, Arivilomi H, Kem P, et al. Importance of intestinalcolodisation in the maturation of humoral immunity in early infancy : aprospective follow up study of healthy infants aged 0-6 months [ J].Arch Child Fetal Neonatal Ed, 2000, 83 (3): 186 - 192.
7Lucky AW,Grote GD,Williams JL,et al. Effect of desonideointment,0.05%,on the hypothalamic-pituitary-adrenal axis ofchildren with atopic deraiatitis[J]. Cutis,1997,59:151-153.
8Mirshahpanah P,Ddcke WD,Merbold U,et al. Superior nuclearreceptor selectivity and therapeutic index of methylprednisoloneaceponate versus mometasone furoate[J],Exp Dermatol,2007,16:753-761.
9Telofski LS,Morello AP 3rd,Mack Correa MC,et al. The infant skinbarrier:can we preserve,protect,and enhance the barrier,[J].Dermatol Res Pract,2012,198:789.
10Pei AY,Chan HH,Ho KM. The effectiveness of wet wrap dressingsusing 0.1% mometasone furoate and 0.005% fluticasone proprionateointments in the treatment of moderate to severe atopic dermatitis inchildren [J]. Pediatr Dermatol,2001,18:343-348.
